We have located links that may give you full text access.
A colorful advantage in iconic memory.
Cognition 2019 June
Synesthesia is a benign neurodevelopmental condition in which stimulation of one sensory modality evokes experiences in a second, unstimulated modality (Simner and Hubbard, 2013). In grapheme-color synesthesia (GCS), which is experienced by 1-2% of adults, synesthetes reliably and involuntarily experience specific colors when viewing blackand-white graphemes. Previous case-studies have identified synesthetes with spectacular memory (Luria, 1968; Smilek, Dixon, Cudahy, & Merikle, 2001) and group studies have found advantages for synesthetes compared to nonsynesthetes in long-term memory (Rothen, Meier, & Ward, 2012). Here, we tested whether similar advantages are also present in earlier stages of memory. We tested visual iconic memory-the sensory store for vision-which has a very large capacity, but decays approximately 1000 ms after stimulus offset (Chow, 1985; Sergent et al., 2013; Sperling, 1960). We tested 20 synesthetes and 20 nonsynesthetes in a direct replication of the Sperling (1960) Partial Report Paradigm using letters (Experiment 1) and non-alphanumeric symbols (Experiment 2) as stimuli. Overall, synesthetes had a greater iconic memory capacity than nonsynesthetes when presented with synesthesia-inducing letter stimuli. This advantage was reduced when they were presented with non-synesthesia inducing symbol stimuli. Critically this advantage was most prominent when memory was stressed by asking participants to remember large arrays. Our results demonstrate that synesthetic memory advantages extend to the earliest stages of memory, and suggest that advantages in later stages of memory may arise from these earlier advantages.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app